270 related articles for article (PubMed ID: 16899196)
1. TACI mutation in common variable immunodeficiency and IgA deficiency.
Rachid R; Castigli E; Geha RS; Bonilla FA
Curr Allergy Asthma Rep; 2006 Sep; 6(5):357-62. PubMed ID: 16899196
[TBL] [Abstract][Full Text] [Related]
2. TACI, isotype switching, CVID and IgAD.
Castigli E; Geha RS
Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
[TBL] [Abstract][Full Text] [Related]
3. TACI is mutant in common variable immunodeficiency and IgA deficiency.
Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS
Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of common variable immunodeficiency.
Castigli E; Geha RS
J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
6. Sequence variants of the TNFRSF13B gene in Czech CVID and IgAD patients in the context of other populations.
Freiberger T; Ravčuková B; Grodecká L; Pikulová Z; Stikarovská D; Pešák S; Kuklínek P; Jarkovský J; Salzer U; Litzman J
Hum Immunol; 2012 Nov; 73(11):1147-54. PubMed ID: 22884984
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency.
Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS
Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508
[TBL] [Abstract][Full Text] [Related]
9. Progression of selective IgA deficiency to common variable immunodeficiency.
Aghamohammadi A; Mohammadi J; Parvaneh N; Rezaei N; Moin M; Espanol T; Hammarstrom L
Int Arch Allergy Immunol; 2008; 147(2):87-92. PubMed ID: 18520152
[TBL] [Abstract][Full Text] [Related]
10. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
[TBL] [Abstract][Full Text] [Related]
11. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
[TBL] [Abstract][Full Text] [Related]
12. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8.
Waldrep ML; Zhuang Y; Schroeder HW
BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471
[TBL] [Abstract][Full Text] [Related]
13. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
14. Role of polymorphisms in the TNFRSF13B (TACI) gene in Spanish patients with immunoglobulin A deficiency.
López-Mejías R; del Pozo N; Fernández-Arquero M; Ferreira A; García-Rodríguez MC; de la Concha EG; Fontán G; Urcelay E; Martínez A; Núñez C
Tissue Antigens; 2009 Jul; 74(1):42-5. PubMed ID: 19392801
[TBL] [Abstract][Full Text] [Related]
15. TACI deficiency - a complex system out of balance.
Salzer U; Grimbacher B
Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095
[TBL] [Abstract][Full Text] [Related]
16. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.
Speletas M; Mamara A; Papadopoulou-Alataki E; Iordanakis G; Liadaki K; Bardaka F; Kanariou M; Germenis AE
J Clin Immunol; 2011 Aug; 31(4):550-9. PubMed ID: 21547394
[TBL] [Abstract][Full Text] [Related]
17.
Karaca NE; Severcan EU; Guven B; Azarsiz E; Aksu G; Kutukculer N
Avicenna J Med Biotechnol; 2018; 10(3):192-195. PubMed ID: 30090215
[TBL] [Abstract][Full Text] [Related]
18. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI).
Koopmans W; Woon ST; Brooks AE; Dunbar PR; Browett P; Ameratunga R
J Clin Immunol; 2013 Jan; 33(1):68-73. PubMed ID: 22983507
[TBL] [Abstract][Full Text] [Related]
19. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.
Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E
J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089
[TBL] [Abstract][Full Text] [Related]
20. TACI mutations and disease susceptibility in patients with common variable immunodeficiency.
Poodt AE; Driessen GJ; de Klein A; van Dongen JJ; van der Burg M; de Vries E
Clin Exp Immunol; 2009 Apr; 156(1):35-9. PubMed ID: 19210517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]